International AIDS Candlelight Memorial

The International AIDS Candlelight Memorial began in 1983. It started in San Francisco and New York. At that time, HIV was new and widely misunderstood. Fear and confusion spread quickly.

In the early years of the epidemic, communities watched friends, partners, colleagues, and neighbors become ill while public understanding lagged behind reality. Misconceptions about transmission led to panic.

Many people experienced rejection, workplace discrimination, and poor treatment in healthcare settings when they needed support most. At the same time, activists, caregivers, and community groups stepped in to provide help, demand compassion, and ensure that those affected were recognized as individuals, not statistics.

A small group of friends living with HIV decided to take action. They created a space where people could mourn together. The first memorials were quiet and deeply personal.

That quiet held significance. During a time when many deaths were not openly acknowledged and grief was often hidden, candlelight offered a way to be seen without confrontation. A candle in a window, carried in a vigil, or placed in a park sent a simple but powerful message: someone is missing, and someone is loved.

Candles illuminated homes and public spaces as symbols of care and support. These early gatherings helped people feel less alone and gave communities a way to remember those who had passed.

They also created a shared space for grief. Many attendees carried multiple losses, friends, community members, caregivers, and mentors. The memorial allowed people to speak names, hold hands, and acknowledge those providing care, organizing support, and standing against discrimination.

As time passed, the memorial spread beyond the United States. Communities around the world began to take part, turning a small initiative into a global tradition.

As it expanded, the memorial adapted to different cultures while keeping its core purpose: remembrance combined with action. In some places, the focus included education and testing, connecting people with healthcare services. In others, it emphasized visibility and human rights, particularly where stigma or discrimination made openness difficult. Candlelight, both simple and symbolic, became a universal expression of remembrance and solidarity.

Over time, the broader understanding of HIV also evolved. Medical advancements transformed it from a devastating diagnosis into a manageable condition with proper care. Antiretroviral therapy has saved many lives and improved the quality of life.

However, access remains uneven. Barriers such as cost, distance, misinformation, and stigma still prevent people from receiving care. The memorial continues to highlight these challenges, reminding communities that progress exists, but work continues.

Today, the Global Network of People Living with HIV leads the effort.

This leadership is important because it centers the voices of those directly affected. It shifts the tone from sympathy to informed understanding, grounded in lived experience, dignity, and practical support. Local organizers shape events to reflect their communities, creating spaces that feel inclusive and supportive.

This network works with organizers worldwide to host events. Each memorial provides a chance to reflect, speak out, and learn. It is not only about grief, but also about resilience, love, and unity.

The memorial carries a clear message: those affected by HIV are not forgotten. This includes those who have died, those living with HIV, and the caregivers and advocates who continue to support communities. Candlelight gatherings honor both loss and life, highlighting stories of connection, creativity, and care.

Together, communities remember the past while working toward a healthier, more informed future. The candles continue to shine, reflecting the ongoing commitment to awareness and support.

In this way, the memorial serves as both a reflection and a guide. It shows the reality of loss and stigma, while pointing toward meaningful responses: learn the facts, communicate with care, support access to treatment and prevention, and treat people living with HIV with dignity. A candle cannot change the past, but it can illuminate the path forward.

HIV has shaped global health for decades, from its silent spread before it was even identified to the major medical breakthroughs that transformed it from a fatal diagnosis into a manageable condition.

These facts highlight how the virus emerged, how it affects the body, and how science and awareness have changed the course of the epidemic.

Retrospective studies of stored blood samples show that HIV was circulating in humans for decades before it was recognized in the early 1980s, with the earliest confirmed HIV-1 sample dating back to 1959 in what is now the Democratic Republic of the Congo.

Genetic analyses suggest the virus likely crossed from chimpanzees to humans in Central Africa around the early 20th century, then slowly spread along trade and migration routes before emerging as a recognized global health crisis.

HIV specifically targets CD4 T lymphocytes, the “helper” cells that coordinate immune responses, by binding to the CD4 receptor and coreceptors on their surface.

Once inside, the virus uses an enzyme called reverse transcriptase to turn its RNA into DNA and integrate into the host genome, gradually depleting CD4 cells and leaving the body vulnerable to opportunistic infections and certain cancers that define AIDS.

When doctors first identified AIDS in 1981, there were no effective treatments, and diagnosis was often seen as a near-certain death sentence.

The introduction of combination antiretroviral therapy in 1996 dramatically changed outcomes, and by 2022, the World Health Organization reported that antiretroviral treatment had averted an estimated 20.8 million AIDS-related deaths worldwide since its scale-up in the early 2000s.

Sub-Saharan Africa remains the region most heavily affected by HIV, accounting for roughly two-thirds of all people living with the virus worldwide despite having about 14% of the global population.

Eastern and Southern Africa alone had an estimated 20.8 million people living with HIV in 2022, but expanded access to antiretroviral therapy has helped reduce AIDS-related deaths in the region by nearly half since 2010.

HIV-related stigma is reinforced by laws in many countries that criminalize HIV exposure, non-disclosure, or transmission, often even when no intent to harm is proven.

UNAIDS reports that as of 2023, at least 134 countries had adopted such HIV-specific or HIV-relevant criminal laws, which public health experts say can discourage people from getting tested or accessing treatment and undermine efforts to control the epidemic.

Daily pre-exposure prophylaxis (PrEP), a medication regimen for HIV-negative people, can reduce the risk of acquiring HIV from sex by about 99% when taken consistently.

For those living with HIV, successful antiretroviral therapy can suppress the virus to “undetectable” levels in the blood, and large studies have shown that people who maintain an undetectable viral load do not sexually transmit HIV to their partners, a concept summarized as “U=U.”

Globally, women and girls, particularly in sub-Saharan Africa, face a disproportionate HIV burden due to a combination of biological vulnerability, gender inequality, and limited access to education and healthcare.

In 2022, adolescent girls and young women aged 15–24 were estimated to account for more than three-quarters of new HIV infections among young people in sub-Saharan Africa, despite representing only a minority of that age group’s population.